Welcome to our dedicated page for Northern Trust SEC filings (Ticker: NTRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Navigating Northern Trust’s multi-layered disclosures can feel like sifting through hundreds of pages of custody metrics, fiduciary liabilities, and Basel III capital tables. If you have ever wondered where to spot changes in trust asset fees or track when long-tenured executives buy shares, this page has you covered.
Stock Titan applies AI-powered summaries to every Northern Trust filing, turning dense language into plain-English insights. Whether you need a “Northern Trust quarterly earnings report 10-Q filing� to see net interest margin trends, or a “Northern Trust insider trading Form 4 transactions� alert to monitor leadership sentiment, our platform delivers real-time updates straight from EDGAR. Key forms are mapped to common questions:
- 10-K: “Northern Trust annual report 10-K simplified� highlights custody fee growth, credit exposure, and segment profitability.
- 10-Q: Instantly compare quarter-over-quarter revenue with “Northern Trust earnings report filing analysis.�
- 8-K: “Northern Trust 8-K material events explained� so you never miss capital actions or leadership changes.
- Form 4: “Northern Trust Form 4 insider transactions real-time� and “Northern Trust executive stock transactions Form 4� reveal buying and selling patterns within hours.
- DEF 14A: “Northern Trust proxy statement executive compensation� outlines pay aligned to return on equity.
From “understanding Northern Trust SEC documents with AI� to spotting dividend policy shifts, our expert analysis saves hours of manual review. Access comprehensive coverage of every filing type, receive real-time alerts, and make informed decisions without wading through arcane footnotes. Northern Trust SEC filings explained simply—so you can focus on strategy, not paperwork.
Northern Trust Corp. (NTRS) filed a Form 4 disclosing two open-market purchases by director Donald Thompson.
- 06/30/2025: 293.49 common shares acquired at $126.79.
- 07/01/2025: 140.49 common shares acquired at $127.99.
After these transactions Thompson directly owns 29,053.86 shares and indirectly controls 1,743 shares via a trust. No derivative activity or dispositions were reported. The Form 4 was signed on 07/02/2025 by an attorney-in-fact.
The combined purchase of roughly 434 shares (about $55,000 at the reported prices) modestly increases the director’s stake and represents routine board compensation or personal investment, rather than a material insider move.
Northern Trust Corporation (NTRS) filed a Form 4 disclosing two small open-market purchases of the company’s common stock by director Chandra Dhandapani.
- 06/30/2025: 266.95 shares acquired at $126.79 per share.
- 07/01/2025: 15.53 shares acquired at $127.99 per share.
The transactions increased the director’s direct holdings from 4,551 shares (estimated) to 4,834.85 shares. The filing notes that the positions are held as stock units payable on a 1-for-1 basis in common stock, indicating participation in a deferred compensation or director equity plan rather than discretionary buying.
No derivative securities were reported. The aggregate value of the purchases is roughly $36,000, an immaterial amount relative to Northern Trust’s market capitalization. Nevertheless, insider purchases generally signal confidence and align directors� interests with shareholders.
Northern Trust Corporation (NTRS) filed a Form 4 disclosing two small open-market purchases of the company’s common stock by director Chandra Dhandapani.
- 06/30/2025: 266.95 shares acquired at $126.79 per share.
- 07/01/2025: 15.53 shares acquired at $127.99 per share.
The transactions increased the director’s direct holdings from 4,551 shares (estimated) to 4,834.85 shares. The filing notes that the positions are held as stock units payable on a 1-for-1 basis in common stock, indicating participation in a deferred compensation or director equity plan rather than discretionary buying.
No derivative securities were reported. The aggregate value of the purchases is roughly $36,000, an immaterial amount relative to Northern Trust’s market capitalization. Nevertheless, insider purchases generally signal confidence and align directors� interests with shareholders.
Form Type: Form 4 (Insider transaction)
Company: Northern Trust Corporation (NTRS)
Reporting Person: Susan Crown, Director
Filing Date: 02-Jul-2025
Transaction Date: 01-Jul-2025
The filing documents a single transaction in which Director Susan Crown acquired 84.11 common-stock units at a stated price of $127.99 per unit. Following the purchase she directly owns 37,404.52 stock-unit equivalents and 18,400 common shares. In addition, Ms. Crown reports indirect holdings of 4,000 shares held in trusts for her children and 339,696 shares held through HCNI II LLC, an entity controlled by family trusts. She expressly disclaims beneficial ownership of the indirectly held shares beyond her proportionate interest.
No derivative securities were transacted, and the filing contains no sales of company shares. The transaction appears to be a routine board-level acquisition—likely part of a deferred-compensation or director-fee program—given the small dollar value (~US$10.8 thousand) relative to Ms. Crown’s overall holdings and the company’s share count.
Materiality assessment: The purchase modestly increases insider direct ownership but is immaterial to Northern Trust’s capital structure and does not signal a notable change to insider sentiment on its own.
Cardio Diagnostics Holdings Inc. (CDIO) � Form 4 insider filing
Director Peter K. Fung reported the grant of 1,736 stock options on 06/30/2025. Each option carries an exercise price of $3.60 and will expire on 06/30/2035. The filing indicates the transaction code “A,� denoting an acquisition rather than a sale. After this award, Fung directly holds 2,443 derivative securities (stock options) linked to CDIO common stock. No open-market purchases or disposals of common shares were disclosed.
Form 4 Insider Transaction Summary
On 07/01/2025, Northern Trust Corporation (NTRS) director Martin P. Slark filed a Form 4 disclosing the acquisition of 66.32 common shares at $127.99 per share (approx. $8.5 k total value). The shares represent deferred stock units that convert 1-for-1 into common stock.
After the award, Mr. Slark’s reported ownership stands at 21,109.92 directly held shares and 4,769 shares held indirectly through a trust. The transaction was coded “A,� denoting an award or exempt acquisition rather than an open-market purchase.
The award increases the director’s direct stake by less than 0.4% and has no effect on Northern Trust’s share count or governance structure. While insider ownership growth can imply confidence, the modest size and routine nature of board compensation make the filing immaterial to the company’s valuation in isolation.
Form 4 Insider Transaction Summary
On 07/01/2025, Northern Trust Corporation (NTRS) director Martin P. Slark filed a Form 4 disclosing the acquisition of 66.32 common shares at $127.99 per share (approx. $8.5 k total value). The shares represent deferred stock units that convert 1-for-1 into common stock.
After the award, Mr. Slark’s reported ownership stands at 21,109.92 directly held shares and 4,769 shares held indirectly through a trust. The transaction was coded “A,� denoting an award or exempt acquisition rather than an open-market purchase.
The award increases the director’s direct stake by less than 0.4% and has no effect on Northern Trust’s share count or governance structure. While insider ownership growth can imply confidence, the modest size and routine nature of board compensation make the filing immaterial to the company’s valuation in isolation.
Blaize Holdings, Inc. (BZAI) � Insider Form 4 Filing
Director George de Urioste reported the grant of 94,361 restricted stock units (RSUs) on 28 June 2025. The award was made at $0 cost to the director and will vest according to the company’s grant agreement (specific vesting schedule not disclosed in the filing). Following the transaction, de Urioste’s direct beneficial ownership stands at 94,361 common shares. No derivative securities or dispositions were reported in Table II, indicating the filing solely reflects a new equity grant rather than an exercise or sale.
The transaction is coded �A,� confirming it is an acquisition stemming from a compensatory award, and not an open-market purchase. While the share count is modest relative to Blaize Holdings� total shares outstanding (not provided in this document), such awards are routine components of director compensation structures and signal continued alignment of management and shareholder interests. However, issuance of new equity does create marginal dilution.
Everi Holdings Inc. (EVRI) � Form 4 filing dated 07/02/2025 discloses that director Geoffrey P. Judge has disposed of his entire equity position in conjunction with the closing of the previously announced merger in which Everi became a wholly-owned subsidiary of Voyager Parent, LLC on 07/01/2025.
- Common shares: 84,240 shares were converted into the right to receive $14.25 cash per share; post-transaction beneficial ownership is 0.
- Stock options: A total of 135,000 options with exercise prices of $1.46 and $3.29 were cancelled and converted into cash equal to the intrinsic value (( $14.25 � exercise price ) × shares), payable on the original vesting schedule.
- Restricted stock units: 95,764 RSUs were cancelled and converted into cash at $14.25 per underlying share, also subject to original vesting terms.
The filing confirms transaction completion (“Effective Time� 07/01/2025) under the July 26 2024 Merger Agreement with International Game Technology PLC (IGT) and affiliated entities. All equity instruments have been converted to cash, indicating Everi’s transition to private ownership and the likely termination of public trading in EVRI shares.
Northern Trust Corp Director Linda Bynoe has filed a Form 144 notice indicating a proposed sale of 8,256 shares of common stock with an aggregate market value of $1,022,092.80. The sale is planned to execute through Northern Trust Securities Inc on the NASDAQ exchange around June 27, 2025.
The shares being sold originated from multiple Restricted Stock Unit (RSU) grants acquired between 2007-2012, with the following breakdown:
- 1,065 shares from May 2007
- 1,244 shares from April 2008
- 1,175 shares from August 2009
- 1,424 shares from April 2010
- 1,625 shares from April 2011
- 1,723 shares from April 2012
The filing confirms no other securities were sold by the insider during the past 3 months. The total shares outstanding for Northern Trust Corp are 194,538,575. The seller has certified no knowledge of undisclosed material adverse information regarding the company's operations.
FAQ
What is the current stock price of Northern Trust (NTRS)?
What is the market cap of Northern Trust (NTRS)?
What are the primary business segments of Northern Trust?
How does Northern Trust differentiate itself in the financial services industry?
Who are the key clientele for Northern Trust?
What is the global reach of Northern Trust?
How does the company ensure service excellence and client trust?
In what ways does Northern Trust incorporate innovation into its operations?
How does Northern Trust manage risk in its financial operations?
What sets Northern Trust apart from other financial institutions?
